Wu Meiling, Zhang Huadan, Kai Jiejing, Zhu Feng, Dong Jingyin, Xu Ziwei, Wong Michael, Zeng Ling-Hui
Department of Pharmacology School of Medicine Zhejiang University City College Hangzhou Zhejiang 310015 China.
Department of Neurology School of Medicine Washington University in St. Louis Saint Louis Missouri 63110.
Ann Clin Transl Neurol. 2017 Dec 27;5(2):138-146. doi: 10.1002/acn3.507. eCollection 2018 Feb.
Whether activation or inhibition of the mTOR pathway is beneficial to ischemic injury remains controversial. It may result from the different reaction of ischemic penumbra and core to modulation of mTOR pathway after cerebral ischemia-reperfusion injury in rats.
Longa's middle cerebral artery occlusion (MCAO) method was conducted to induce the focal cerebral ischemia-reperfusion. Western blot analysis was used to examine the protein expression involving mTOR pathway, apoptosis, and autophagy-related proteins. TTC staining and Fluoro-Jade B staining was conducted to detect the infarct volume and cell apoptosis, respectively. Neurological function was measured by modified neurological severity score and left-biased swing.
mTOR signaling pathway was activated in ischemic penumbra and decreased in ischemic core after ischemia and ischemia-reperfusion. Ischemia-reperfusion injury induced the increase in cleaved caspase 9 and caspase 3 both in ischemic penumbra and in ischemic core, whereas the expression of phosphorylated ULK1, Beclin 1 and LC3-II was decreased. Rapamycin pre or postadministration inhibited the overactivation of mTOR pathway in ischemic penumbra. Ameliorated neurological function and reduced infarct volume were observed after pre or postrapamycin treatment. Rapamycin markedly decreased the number of FJB-positive cells and the expression of cleaved caspase-3 and cleaved caspase-9 proteins as well as increased the activation of autophagy reflected by ULK1, Beclin-1 and LC3.
mTOR signaling pathway was activated in ischemic penumbra after cerebral ischemia-reperfusion injury in rats. mTOR inhibitor rapamycin significantly decreased the mTOR activation and infarct volume and subsequently improved neurological function. These results may relate to inhibition of neuron apoptosis and activation of autophagy.
mTOR通路的激活或抑制对缺血性损伤是否有益仍存在争议。这可能源于大鼠脑缺血再灌注损伤后,缺血半暗带和核心区对mTOR通路调节的不同反应。
采用Longa大脑中动脉闭塞(MCAO)法诱导局灶性脑缺血再灌注。运用蛋白质免疫印迹分析检测涉及mTOR通路、凋亡和自噬相关蛋白的表达。分别采用TTC染色和Fluoro-Jade B染色检测梗死体积和细胞凋亡。通过改良神经功能缺损评分和左侧摆动试验评估神经功能。
缺血及缺血再灌注后,mTOR信号通路在缺血半暗带被激活,在缺血核心区降低。缺血再灌注损伤导致缺血半暗带和缺血核心区中裂解的caspase 9和caspase 3增加,而磷酸化ULK1、Beclin 1和LC3-II的表达降低。雷帕霉素给药前或给药后均可抑制缺血半暗带中mTOR通路的过度激活。雷帕霉素给药前或给药后治疗均观察到神经功能改善和梗死体积减小。雷帕霉素显著减少FJB阳性细胞数量以及裂解的caspase-3和裂解的caspase-9蛋白的表达,并增加由ULK1、Beclin-1和LC3反映的自噬激活。
大鼠脑缺血再灌注损伤后,缺血半暗带中mTOR信号通路被激活。mTOR抑制剂雷帕霉素显著降低mTOR激活和梗死体积,随后改善神经功能。这些结果可能与抑制神经元凋亡和激活自噬有关。